ADVL1315: A Phase 1 Study of the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib (INLYTA, IND# 123101) in Children with Recurrent or Refractory Solid Tumors.

  • Goldman, Stewart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/13/159/30/16

Funding

  • Children's Hospital of Philadelphia
  • Pfizer Inc.